The influence of Durvalumab/Tremelimumab Combination Therapy on Sarcomas Immune Microenvironment profile in a phase II clinical trial (NCT02815995)
Edwin Parra,Carmelia Barreto,Ruth Salazar,Cara Haymaker,Heather Lin,Carmen Behrens,Mei Jiang,Luisa Solis, Krishna Pandurenga,Sandesh Subramanya,Young Kim,Chantale Bernatchez,Jack Lee,Taylor Tate, Teresa Simmons,Alexander Lazar,Wei-Lien Wang,Zachary Cooper,Jaime Rodriguez-Canales,Jean Soria,Anthony Conley,Ignacio Wistuba,Neeta Somaiah JOURNAL FOR IMMUNOTHERAPY OF CANCER（2019）
AI 理解论文
溯源树
样例
